Results 121 to 130 of about 5,934 (217)

Low doses of lysergic acid diethylamide (LSD) increase reward-related brain activity. [PDF]

open access: yesNeuropsychopharmacology, 2023
Glazer J   +4 more
europepmc   +1 more source

Recent national trends in Salvia divinorum use and substance-use disorders among recent and former Salvia divinorum users compared with nonusers

open access: yesSubstance Abuse and Rehabilitation, 2011
Li-Tzy Wu1, George E Woody2, Chongming Yang3, Jih-Heng Li4, Dan G Blazer11Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, USA; 2Department of Psychiatry, University of Pennsylvania and Treatment Research ...
Blazer DG   +4 more
doaj  

Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants. [PDF]

open access: yesNeuropsychopharmacology, 2023
Ley L   +13 more
europepmc   +1 more source

Adverse experiences resulting in emergency medical treatment seeking following the use of lysergic acid diethylamide (LSD). [PDF]

open access: yesJ Psychopharmacol, 2022
Kopra EI   +6 more
europepmc   +1 more source

Lysergic Acid Diethylamide Modulation of Motor Seizures and Hippocampal and Cortical Oscillatory Rhythms

open access: yes
Lysergic acid diethylamide (LSD) is a psychedelic drug with therapeutic promise in psychiatry and neurology. Its acute effects on seizures or cortico-hippocampal oscillatory rhythms are unknown. This thesis was a two-armed investigation into both.
Rabinovitch, Brenden Samuel
core  

Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide Microdoses in Healthy Participants. [PDF]

open access: yesClin Pharmacol Ther, 2021
Holze F   +9 more
europepmc   +1 more source

Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects. [PDF]

open access: yesNeuropsychopharmacology, 2022
Holze F   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy